Drug Topics

JANUARY 9, 2023

Custom is one of the growing number of companies focusing on adherence. It changed its name from Pack4U last year.

185

185

Pharmacy Times

JANUARY 9, 2023

Relative risk calculations show that vaccinated individuals infected with the first Omicron subvariants of COVID-19 could have protection that lasts nearly 3 seasons.

Immunization 132

Immunization Vaccines 132

Drug Topics

JANUARY 9, 2023

Pharmacists can make simple changes that add up to big environmental impacts.

201

201

Pharmacy Times

JANUARY 9, 2023

The chronic and excessive use of opioids has been associated with a wide range of psychosocial effects on the patient.

156

156

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

JANUARY 9, 2023

Approval followed resubmission of data from the phase 3 CONFIRM trial to the agency.

FDA 187

FDA 187

STAT

JANUARY 9, 2023

SAN FRANCISCO –  U.S. Food and Drug Administration commissioner Robert Califf doesn’t disagree with the basic findings of a congressional investigation into the agency’s role in the controversial approval of Aduhelm, Biogen’s first Alzheimer’s drug. He just wishes the report’s tone had been different. “There were no surprises in the report,” Califf told STAT’s Matt Herper during a Monday night event hosted by STAT during the J.P

FDA 125

FDA 125

STAT

JANUARY 9, 2023

Senior-focused primary care providers Oak Street Health and Agilon Health used their stage time at the J.P. Morgan Healthcare Conference in San Francisco on Monday to talk up their ambitious growth plans in the coming year. Both Oak Street and Agilon’s business models are centered around the Medicare Advantage program, the private form of Medicare for people over 65.

Insurance 118

Insurance Hospitals 118

Fierce Healthcare

JANUARY 9, 2023

CVS, Cigna back kidney care coordination, tech startup Monogram Health's latest $375M raise. dmuoio. Mon, 01/09/2023 - 12:24.

144

144

pharmaphorum

JANUARY 9, 2023

Novartis’ programme providing free access to its spinal muscular atrophy (SMA) gene therapy Zolgensma is being scaled back to a dozen countries worldwide, according to the company. First introduced in 2020, the global Managed Access Programme (gMAP) has provided Zolgensma (onasemnogene abeparvovec) free of charge to nearly 300 children with the genetic disorder across 36 countries where the therapy has not yet received approval or in which no formal access pathway exists.

118

118

Fierce Pharma

JANUARY 9, 2023

JPM23, Day 1: BMS touts new launches as patent cliff looms; Regeneron's Eylea sales disappoint. esagonowsky. Mon, 01/09/2023 - 09:55.

139

139

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

JANUARY 9, 2023

We’re preparing to start JP Morgan week with a busy day Monday, with day 1 of the Informa Biotech Showcase, including a dedicated mini-event on Cell and Gene Therapy in the morning. Then in the evening, we’ll be at STAT@JPM for presentations by event sponsor GSK as well as the guest of honour: FDA Commissioner Robert Califf. Check below for updates throughout the day.

FDA 118

FDA 118

STAT

JANUARY 9, 2023

Cough medicine tainted with ethylene glycol that killed at least 19 children in Uzbekistan in late December 2022 has once again revealed lax oversight and regulation of pharmaceutical companies based in India. That preventable tragedy, which involves products made by Marion Biotech, based in Noida, India, echoes earlier cases. In the summer of 2022, at least 70 children in Gambia died from kidney failure after using cough medicine made by India-based Maiden Pharmaceuticals that contained ethylen

Pharmaceutical Companies 110

Pharmaceutical Companies Pharmaceutical Companies 110

Pharmacy Times

JANUARY 9, 2023

Mothers, in particular, benefit when they are given longer leaves and policies that offer incentives or wage replacement, analysis indicates.

123

123

Fierce Pharma

JANUARY 9, 2023

JPM23: Moderna reaped $18.4B in COVID vaccine sales last year, projects at least $5B in 2023. kdunleavy. Mon, 01/09/2023 - 10:34.

Vaccines 131

Vaccines 131

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JANUARY 9, 2023

Black patients aged 18 to 49 years showed a greater association with uncontrolled blood pressure while on an antihypertensive medication.

122

122

STAT

JANUARY 9, 2023

Moderna disclosed Monday that it plans to price its Covid-19 vaccine at anywhere from $110 to $130 per dose when the company pivots from a focus on government contracts to commercial distribution efforts. The timing was not disclosed, but the company is holding talks with hospitals, pharmacy chains and pharmacy benefit managers. In setting such a price, Moderna will pursue the same path as Pfizer, which last year also announced plans to charge $110 to $130 a dose this year for its own Covid-19 s

Vaccines 103

Vaccines Hospitals 103

Fierce Healthcare

JANUARY 9, 2023

These socioeconomic factors may be indicators of long COVID risk, study says. fdiamond. Mon, 01/09/2023 - 16:48.

133

133

STAT

JANUARY 9, 2023

“Living With” explores the contours of life with chronic illness, from the prelude to diagnosis to new patterns of living, to wrestling with big questions about illness and health. Kristin Houlihan, 38, got sick in March 2020 with a virus she assumes was Covid. She wasn’t sick, in a flu-like sense, for long. But then, some symptoms never went away: night sweats, extreme temperature swings after meals.

103

103

Drug Store News

JANUARY 9, 2023

Sally Hansen’s Salon Effects Perfect Manicure collection consists of ready-to-wear press-on nails that come in a variety of nail lengths, shapes, colors and designs.

105

105

STAT

JANUARY 9, 2023

The surge in telehealth during the pandemic promised to shed light on a crucial question: Does the convenience of telehealth drive up costs when patients make more appointments than they would in-person? The answer stands to shape investments in — and oversight of — the fast-growing field. But three years in, the mountain of telehealth claims data has created a fresh set of questions, and left regulators, insurers, researchers, and health systems with a newfound recognition that vi

Insurance 103

Insurance 103

Drug Store News

JANUARY 9, 2023

Novartis AG agreed to pay $245 million to end antitrust litigation accusing the company of trying to delay the launch of generic versions of the drug Exforge in the United States.

98

98

STAT

JANUARY 9, 2023

A new study suggests physician practices acquired by private equity rely more heavily on advanced practice providers like nurse practitioners and physician assistants and experience higher churn compared with their non-private equity owned peers. The researchers used clinician-level and practice acquisition data to study changes in the makeup of clinician workforces at private equity-acquired versus non-private equity-acquired dermatology, ophthalmology, and gastroenterology practices between 20

Hospitals 101

Hospitals Insurance 101

The Checkup by Singlecare

JANUARY 9, 2023

If you’re considering quitting smoking, or have recently given it up, congratulations! No matter how long you’ve been smoking, quitting is one of the best things you can do for your health. But for all its benefits—and there are many !—it’s not an easy road. You can expect withdrawal symptoms to peak at three days after stopping (and to subside within a month).

Labelling 98

Labelling 98

STAT

JANUARY 9, 2023

Children struggling with obesity should be evaluated and treated early and aggressively, including with medications for kids as young as 12 and surgery for those as young as 13, according to new guidelines released Monday. The longstanding practice of “watchful waiting,” or delaying treatment to see whether children and teens outgrow or overcome obesity on their own only worsens the problem that affects more than 14.4 million young people in the U.S.

101

101

Pharmaceutical Technology

JANUARY 9, 2023

Eisai and Biogen have received approval for their antibody Leqembi (lecanemab-irmb) , 100mg/mL injection for intravenous use, from the US Food and Drug Administration (FDA) under the Accelerated Approval Pathway to treat Alzheimer’s disease (AD). Leqembi is indicated to treat mild cognitive impairment or mild dementia stage of the disease in patients whose treatment started in clinical trials.

FDA 98

FDA 98

STAT

JANUARY 9, 2023

Although artificial intelligence is entering health care with great promise, clinical AI tools are prone to bias and real-world underperformance from inception to deployment, including the stages of dataset acquisition, labeling or annotating, algorithm training, and validation. These biases can reinforce existing disparities in diagnosis and treatment.

Labelling 101

Labelling FDA 101

PharmExec

JANUARY 9, 2023

"The customer is always right" — a commitment to omnichannel marketing is a commitment to serving the customer. David Laros of Beghou Consulting offers up this tersely written playbook on the topic.

98

98

STAT

JANUARY 9, 2023

In the past year, there’s been a significant surge in interest in medication abortion via telehealth, after the Supreme Court overturned Roe v. Wade and the Food and Drug Administration made it possible for patients to get a prescription online and have the drug delivered to their front doors. Now, telemedicine patients will have more pathways to care.

FDA 101

FDA 101

The Checkup by Singlecare

JANUARY 9, 2023

Living with diabetes can be manageable, but that doesn’t mean it’s always easy when living with the condition. One less than stellar requirement of managing your diabetes is the daily finger pricks needed to monitor your blood sugar levels. But what if there was a way to track your blood sugar accurately without the constant needle sticks? What is FreeStyle Libre ?

Insurance 97

Insurance 97

STAT

JANUARY 9, 2023

SAN FRANCISCO — Regeneron said Monday that it collected $1.5 billion in revenues from its blockbuster eye degeneration drug Eylea in the fourth quarter — a substantial sum for many companies but a possible poor omen for the New York-based biotech. The figures, released ahead of Regeneron’s JPM presentation on Monday, were substantially below analyst projections.

101

101

pharmaphorum

JANUARY 9, 2023

Eisai and Biogen’s Alzheimer’s therapy Leqembi will be priced at $26,500 per year – a little less than misfired predecessor Aduhelm – after getting conditional authorisation for the drug from the FDA on Friday. The US regulator has granted accelerated approval to anti-amyloid therapy Leqembi (lecanemab) with a fairly broad label to treat patients in the mild cognitive impairment or mild dementia stage of disease who have confirmed presence of amyloid pathology.

FDA 96

FDA Labelling 96

STAT

JANUARY 9, 2023

SAN FRANCISCO — In some of his first extended comments since taking over as Biogen’s CEO, Chris Viehbacher described the commercial launches this year of an Alzheimer’s treatment and a new medicine for depression as “breakthrough” products will help the company return to sustainable growth. But Viehbacher also acknowledged he has about six months of internal work ahead of him to fix the company’s cost structure.

98

98

pharmaphorum

JANUARY 9, 2023

Biopharma and healthcare group Chiesi Farmaceutici S.p.A. is to acquire the 2015-established Amryt Pharma Plc. in an all-cash transaction at $14.50 per American Depositary Share (ADS). Each ADS represents five Amryt ordinary shares. Supported by voting agreements from leading Amryt shareholders and directors, and unanimously approved and recommended by the boards of both companies, the total transaction is worth up to $1.48 billion, with upfront consideration of $1.25 billion representing a 107%

FDA 91

FDA 91

STAT

JANUARY 9, 2023

WASHINGTON — The head of South Dakota prisons is pledging to dramatically overhaul how the system treats hepatitis C in the coming year. South Dakota’s new hepatitis C policy for incarcerated people, which is not yet final or public, will treat all people with hepatitis C for the virus, regardless of the stage of their infection, Corrections Secretary Kellie Wasko told STAT in an interview Monday.

98

98